Lialda Oral

If you have ulcerative colitis, your healthcare provider may recommend treatment with Lialda® (mesalamine), an oral medication that is taken just once a day. Because the tablets have a special delayed-release coating, the drug is able to work in the colon without dissolving first.
In one study, up to 41.2 percent of people taking the drug for mild-to-moderately active ulcerative colitis experienced remission within eight weeks, compared to just 22.1 percent of those not taking it. In this study, ulcerative colitis remission was defined as:
(Click Lialda to learn more about this oral medication. This article takes a closer look at the effects of the drug, with information on how it works, potential side effects, and more.)
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.